Bio-Rad Laboratories Inc.BIO

Health Care · Pharmaceuticals, Biotechnology & Life Sciences · NYSE · United States · bio-rad.com

Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized products for life science research and clinical diagnostics, founded in 1952 and headquartered in Hercules, California. The company operates through Life Science (instruments, reagents, and systems for biological research and biopharmaceutical production) and Clinical Diagnostics (test systems, informatics systems, and quality controls for global clinical laboratories) segments.

Key ratios

Operating cash flow growth

-7.8%TTM

2025 16.9%2024 21.4%2023 92.9%

EPS growth

-28.2%TTM

FCF / Sales

13.6%TTM

2025 14.5%2024 11.3%2023 8.2%

Net margin

8.6%TTM

2025 29.4%2024 -71.9%2023 -23.9%

ROA

1.7%TTM

2025 1.7%2024 1.7%2023 1.8%

ROE

3.1%TTM

2025 10.8%2024 -24.1%2023 -6.9%

Revenue growth

1.4%TTM

2025 0.7%2024 -3.9%2023 -4.7%

Recent news

Bio-Rad receives MicroVal validation for EZ-Check™ Listeria testing kits 2026-06-05 · News-Medical.net

Track BIO in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer